Evidence map›Paper›PMID 37838934›Full record

ArticleIranian journal of kidney diseases2023

The Effect of Moringa Isothiocyanate-1 on Renal Damage in Diabetic Nephropathy.

Lijing Chen, Deyong Fan, Fei Guo, Jiuhong Deng, Linlin Fu

Abstract readComment
PubMed Publisher
In one paragraph

Article in Iranian journal of kidney diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lijing ChenDepartment of Nephrology, Huzhou Central Hospital and Affiliated Central Hospital Huzhou University, 313000 Huzhou, Zhejiang, China
Deyong FanDepartment of Nephrology, Huzhou Central Hospital and Affiliated Central Hospital Huzhou University, 313000 Huzhou, Zhejiang, China
Fei GuoDepartment of TCM Acupuncture, Huzhou Central Hospital and Affiliated Central Hospital Huzhou University, 313000 Huzhou, Zhejiang, China
Jiuhong DengWenzhou Medical University. Wenzhou Medical University, Chashan Higher Education Park, Wenzhou, Zhejiang, China; The Second Affiliated Hospital Zhejiang University, School of Medicine, 310009 Hangzhou, Zhejiang, China
Linlin FuDepartment of Pathology, Huzhou Central Hospital and Affiliated Central Hospital Huzhou University, 313000 Huzhou, Zhejiang, China
Huzhou Central Hospital · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDiabetic nephropathy (DN) is the most common clinical complication of diabetes mellitus. Moringa isothiocyanate-1 (MIC-1) is effective in the treatment of diabetes mellitus, but its mechanism of action in DN remains obscure. This research specifically probed the role of MIC-1 in modulating renal injury in DN.

methodsSix db/m mice were assigned to control group and twelve db/db mice were randomly allocated to the db/db and db/db + MIC-1 groups. The body and kidney weights of the mice were monitored. Renal function indicators and oxidative stress-related markers were assessed by automatic biochemical analyzer and ELISA method. The pathological changes, apoptosis of renal tissues, extracellular regulated protein kinases (ERK) 1/2/ Nuclear factor erythroid2-related factor 2 (Nrf2) pathway-related markers, and the positive expressions of podocalyxin (Pod) and synaptopodin (Syn) were measured by H&E, PAS, and TUNEL staining, Western blot, and IHC assay.

resultsMIC-1 reduced the body and kidney weights, and increased the kidney organ index (calculated as 100*kidney weight/ body weight) in db/db mice. In addition, MIC-1 improved renal function, kidney tissue injury, and apoptosis of db/db mice. MIC1 noticeably repressed the contents of reactive oxygen species (ROS) and malondialdehyde (MDA) and enhanced the contents of (glutathione) GSH, superoxide dismutase (SOD), and catalase (CAT) in db/db mice. At molecular level, db/db mice showed a decrease in p-ERK/ERK, Nrf2, SOD-1, heme oxygenase 1 (HO-1), and CAT and an increase in p- inhibitor kappa B alpha (IKBα) and p-Nuclear factor-kappa B (P65/P65), which were reversed when MIC-1 was administered. Furthermore, MIC-1 facilitated the positive expressions of Pod and Syn of the kidney tissues in db/db mice.

conclusionMIC-1 reduces oxidative stress and renal injury by activating the ERK/Nrf2/HO-1 signaling and repressing the NFκB signaling in db/db mice.

Indexed as

Diabetes MellitusDiabetic NephropathiesMoringaAnimalsGlutathioneIsothiocyanatesKidneyMiceNF-E2-Related Factor 2Oxidative StressGlutathioneIsothiocyanatesNF-E2-Related Factor 2diabetic nephropathyERK1/2/Nrf2 pathwaymoringa isothiocyanate-1oxidative stressrenal injury

Identifiers

PMID37838934
OpenAlexW4387649878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.